Trading Summary - December 31. $EVSV closed out yet

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
350
Trading Summary - December 31.

$EVSV closed out yet another successful year as #6 Top Profit Earner on my Watch List - with $multiple 5-figures in banked profits for those that followed and traded continuously for the whole year - particularly for those that took advantage of the day's warning given of the r/s and followed my proven strategy for trading successfully through one - hold all shares - load bottom prices available before the r/s - trade aggressively from the bottom up on all surges including buying the ask - reload during quiet periods between surges.

For the 3rd year running, banked profits on $EVSV were roughly the same bringing a total of $6-figures within reach when anticipated 2020 profits are included.

$EVSV will remain a Top Pick for 2020 - and may even get promoted to the #2 slot from #3 - depending on developments over the next few weeks.

Today was a status quo day as expected - with nonsense being ramped up on iHub by the usual scammers trying to dupe people to sell / not buy, 1 x insignificant paint down attempt with 741 shares, and the fake undercut ask at .3910 (where it retreated yesterday) being taken down for a few hours then put up again.

The fact remains that the majority of the cheapest lots of shares - in the .2500 > .3999 range - and in the .4000 to .5000 range - remain in the hands of the relatively few top traders / long term traders of $EVSV who are already well set up for all the upwards surges expected in 2020 as PRs, filings and other updates roll out on expansion of the Hemp Division, increased revenue of the Pest Control Division, any other private equity investors, and a possible share buyback already alluded to again recently.

Ahead from January 2 we can expect to see at least 2 x PRs and ask hits.

Items below the line unchanged since the last long-version Trading Summary:

Top traders of $EVSV have now each earned close to $6-figures on it in the last 3 years and multiple $5-figures in 2019 - most of which is since the successful r/s 11 months ago - due to multiple surges and the thin share structure for a stock in this price range.

The latest DD / Rolling Brief is here: https://investorshangout.com/Enviro-Serv-Inc-EVSV-67882/

Key Points from recent PRs (not including December 17 PR) are here:

https://investorshangout.com/post/view?id=5619497

The Share Structure was last updated on November 29, 2019 - showing no significant change from the previous update.

The 2019 Q3 was filed on November 18, 2019 in a timely manner.

The 2019 Q2 was filed on August 7, 2019 in a timely manner and gave a very good description of the holding company $EVSV's current portfolio and partnerships (unable to copy - read in filing).

Trading on December 17 illustrated yet again just how difficult it is to accumulate an inventory of 100K > 150K of $EVSV - like the top traders in it have - to be ready for the move to $1+ - within even a .2000 price band increment.

The next buyer of 100K at a time should see .6000 or .7000 up - and the next 200K might see $1+.

The top traders in $EVSV aren't going to waste out time nickel and diming trying to fill on the bid when there is so much else going on with Watch List stocks to attend to daily. We will just take out everything on the ask under 1.000 at a time of our choosing.

Top traders who are the movers and shakers of $EVSV will continue the transfer of more of their profits from other trades into $EVSV up until the first hemp crop revenues come out.

The usual moving around of the insignificant undercut asks by the iHub scammers of course has no effect and they are currently being allowed to continue to post to themselves on iHub completely oblivious to the fact that all traders of significance are networking by other means on telegram and slack.

The modus operandi of the iHub scammers hasn't changed for 11 months since they failed to buy at .0001 on the day before the successful r/s: post blatant nonsense on iHub + attempt to support their fake narrative by trading at or below the visible bid price (often with orders placed before the open + then not pay attention to actual other trading that follows + attempt to walk a small ask down to artificially low levels + not realize that their manipulation attempts don't affect the views of the 172 social media OTC influencers who have $EVSV on their radar now.

All these manipulation attempts enable top traders on low commission rates - who don't have to worry about partial fills - to just keep accumulating cheap shares almost daily.

I'll be mainly #boycottiHub - I have now alerted the more influential / serious Penny Stock Geeks and relevant Whale Team rooms on telegram and slack.

In addition of course we have 177 traders / analysts / alerters on social media that have $EVSV on their radar to start scaling in and / or jumping on board "just-in-time".

Warning ! Anyone who is seen posting nonsense on iHub on any on the thinly traded stocks I'm a shareholder in - especially when small paint downs are also seen along with undercut asks - can expect to have their user ID passed to the SEC which has now started to take action against those using the exact modus operandi I have detected and commented on for the past 2 years. They are also likely to get detected by their broker's compliance department who - in addition to reporting them to the SEC - can liquidate their entire account at market order prices on the bid side and close their account.

https://www.sec.gov/news/press-release/2019-216





Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading